From: Prospective adherence to specific immunotherapy in Europe (PASTE) survey protocol
Author | Study population (pts) | Age (A/C) | Study duration | Adherence rate (%) |
---|---|---|---|---|
Marogna (2004) [35] | 319 | A | 3y | 85 |
Lombardi (2004) [36] | 86 | A | 18Â m | 79-97 |
Pajno (2005) [27] | 806 | C | 3y | 79 |
Passalacqua (2006) [37] | 443 | A | 6Â m | 76 |
Passalacqua (2007) [38] | 71 | C | 6Â m | 85 |
Cadario (2008) [39] | 40 | A | 1y | 65 |
Roder (2008) [40] | 154 | A | 2y | 77 |
Chang (2009) [41] | 142 | A/C | 6Â m | 69 |
Jansen (2009) [42] | 91 | A | 6Â m | 95 |
Ott (2009) [43] | 183 | A/C | 2y | 91 |
Vita (2010) [44] | 300 | C | 2y | 30-76 |
Pajno (2012) [45] | 150 | C | 2y | 54 |
Hsu & Reisacher (2012) [31] | 139 | A | 4y | 59 |
Kiel (2013) [33] | 3.690 | A | 3y | 7 |
Trebuchon (2014) [46] | 736 | C | 2Y | 86 |